A citation-based method for searching scientific literature

Philipp Koch, Peter Breuer, Michael Peitz, Johannes Jungverdorben, Jaideep Kesavan, Daniel Poppe, Jonas Doerr, Julia Ladewig, Jerome Mertens, Thomas Tüting, Per Hoffmann, Thomas Klockgether, Bernd O Evert, Ullrich Wüllner, Oliver Brüstle. Nature 2011
Times Cited: 233



Ronald A M Buijsen, Lodewijk J A Toonen, Sarah L Gardiner, Willeke M C van Roon-Mom. Neurotherapeutics 2019
Times Cited: 54




List of shared articles



Times cited

Human Induced Pluripotent Stem Cell-Based Modelling of Spinocerebellar Ataxias.
Marina P Hommersom, Ronald A M Buijsen, Willeke M C van Roon-Mom, Bart P C van de Warrenburg, Hans van Bokhoven. Stem Cell Rev Rep 2022
2

miRNA-Mediated Knockdown of ATXN3 Alleviates Molecular Disease Hallmarks in a Mouse Model for Spinocerebellar Ataxia Type 3.
Rui Jorge Nobre, Diana D Lobo, Carina Henriques, Sonia P Duarte, Sara M Lopes, Ana C Silva, Miguel M Lopes, Fanny Mariet, Lukas K Schwarz, M S Baatje,[...]. Nucleic Acid Ther 2022
1

Advances in Modeling Polyglutamine Diseases Using Genome Editing Tools.
Marianna Karwacka, Marta Olejniczak. Cells 2022
0

Human stem cell models of polyglutamine diseases: Sources for disease models and cell therapy.
Lang He, Zhao Chen, Linliu Peng, Beisha Tang, Hong Jiang. Exp Neurol 2021
4

Artificial miRNAs as therapeutic tools: Challenges and opportunities.
Anna Kotowska-Zimmer, Marianna Pewinska, Marta Olejniczak. Wiley Interdiscip Rev RNA 2021
5

Therapeutic roles of natural remedies in combating hereditary ataxia: A systematic review.
Michael Weng Lok Phang, Sze Yuen Lew, Ivy Chung, William Kiong-Seng Lim, Lee Wei Lim, Kah Hui Wong. Chin Med 2021
1


CRISPR/Cas9 mediated gene correction ameliorates abnormal phenotypes in spinocerebellar ataxia type 3 patient-derived induced pluripotent stem cells.
Lang He, Shang Wang, Linliu Peng, Huifang Zhao, Shuai Li, Xiaobo Han, Jean de Dieu Habimana, Zhao Chen, Chunrong Wang, Yun Peng,[...]. Transl Psychiatry 2021
2

Pathogenesis of SCA3 and implications for other polyglutamine diseases.
Hayley S McLoughlin, Lauren R Moore, Henry L Paulson. Neurobiol Dis 2020
46


Polyglutamine spinocerebellar ataxias: emerging therapeutic targets.
Andreia Neves-Carvalho, Sara Duarte-Silva, Andreia Teixeira-Castro, Patrícia Maciel. Expert Opin Ther Targets 2020
3

Modeling Polyglutamine Expansion Diseases with Induced Pluripotent Stem Cells.
Swati Naphade, Kizito-Tshitoko Tshilenge, Lisa M Ellerby. Neurotherapeutics 2019
10